By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Tonix Pharmaceuticals Holding Corp. insiders have been one-way buyers this past year: four people put roughly $459,000 into the stock and nobody sold in open-market trades.
Biggest single buyer: LEDERMAN SETH, CEO, with roughly $223,000. C-suite participation is part of the picture here.
Looking at the quarterly pattern: 3 quarters in a row of net buying by insiders. Insiders bought in 5 of the last 7 full quarters. Big money check: 102 institutions held TNXP as of Q2 2026, and more funds bought than sold.
Are insiders buying or selling TNXP stock?
In the last 12 months Tonix Pharmaceuticals Holding Corp. insiders made open-market purchases worth about $459,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in TNXP?
The most recent open-market insider trade in TNXP was filed on 2026-08-31.
How many institutions own TNXP?
102 investment managers reported holding TNXP in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded TNXP?
No congressional trades in TNXP were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).